Nicole Contran
Overview
Explore the profile of Nicole Contran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
70
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jafarnezhad-Ansariha F, Contran N, Cristofori C, Simonato M, Davanzo V, Moz S, et al.
Cancers (Basel)
. 2025 Feb;
17(4).
PMID: 40002238
Pancreatic cystic neoplasms (PCNs), particularly intraductal papillary mucinous neoplasms (IPMNs), present a challenge for their potential malignancy. Despite promising biomarkers like CEA, amylase, and glucose, our study investigates whether metabolic...
2.
Aita A, Galozzi P, Zemin F, Principi G, Contran N, Musso G, et al.
PLoS One
. 2024 Nov;
19(11):e0314234.
PMID: 39585877
Objective: Salivary alpha-amylase (sAA) has been recently proposed as biomarker of stress responsiveness within the sympathetic nervous system, preferable to cortisol, since limitations related to cortisol measurement (e.g. diurnal and...
3.
Contran N, Arrigoni G, Battisti I, DInca R, Angriman I, Franchin C, et al.
Sci Rep
. 2024 Jul;
14(1):17711.
PMID: 39085299
Inflammatory bowels diseases (IBD) are high risk conditions for colorectal cancer (CRC). The discovery of IBD and CRC noninvasive protein/peptide biomarkers using saliva and feces was the aim of this...
4.
Padoan A, Musso G, Contran N, Basso D
Curr Issues Mol Biol
. 2023 Jul;
45(7):5534-5557.
PMID: 37504266
In this review, the role of innate and adaptive immunity in the pathogenesis of inflammatory bowel diseases (IBD) is reported. In IBD, an altered innate immunity is often found, with...
5.
Aita A, Navaglia F, Moz S, Contran N, Barbaro F, Cattelan A, et al.
Clin Chem Lab Med
. 2022 Oct;
61(2):323-331.
PMID: 36282616
Objectives: The rapid, accurate and safe detection of SARS-CoV-2 is the key to improving surveillance and infection containment. The aim of the present study was to ascertain whether, after heat/chemical...
6.
Aita A, Battisti I, Contran N, Furlan S, Padoan A, Franchin C, et al.
Clin Chim Acta
. 2022 Oct;
537:26-37.
PMID: 36228679
Background And Aim: SARS-CoV-2 infection spawns from an asymptomatic condition to a fatal disease. Age, comorbidities, and several blood biomarkers are associated with infection outcome. We searched for biomarkers by...
7.
Basso D, Aita A, Padoan A, Cosma C, Navaglia F, Moz S, et al.
Clin Chim Acta
. 2021 Feb;
517:54-59.
PMID: 33626369
Background And Aim: SARS-CoV-2 quick testing is relevant for the containment of new pandemic waves. Antigen testing in self-collected saliva might be useful. We compared salivary and naso-pharyngeal swab (NPS)...
8.
Moz S, Contran N, Facco M, Trimarco V, Plebani M, Basso D
Biomolecules
. 2020 Jul;
10(7).
PMID: 32679840
Combined approaches based on immunotherapy and drugs supporting immune effector cell function might increase treatment options for pancreatic ductal adenocarcinoma (PDAC), vitamin D being a suitable drug candidate. In this...
9.
Basso D, Padoan A, DInca R, Arrigoni G, Scapellato M, Contran N, et al.
Clin Chem Lab Med
. 2020 Apr;
58(6):968-979.
PMID: 32229654
Background The sensitivities and specificities of C-reactive protein (CRP) and faecal calprotectin (fCal), as recommended for inflammatory bowel diseases (IBD) diagnosis and monitoring, are low. Our aim was to discover...